Form 4 for TRAW Traws Pharma, Inc.
Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-10 · accession 0001415889-24-017636 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-20 | 2024-06-18 | TRAW | Guerin Mark Patrick | CFO | F - Tax | $0.47 | -2,221 | 39.3K | -5% | -$1,044 |
| D | 2024-06-20 | 2024-06-10 | TRAW | Guerin Mark Patrick | CFO | M - OptEx | — | +5,500 | 41.5K | +15% | — |
| D | 2024-06-20 | 2024-06-18 | TRAW | Guerin Mark Patrick | CFO | M - OptEx | $0.00 | -5,500 | 5,500 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-18 | F | D | 2,221 | $0.47 | 39,255 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-10 | M | A | 5,500 | — | 41,476 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2024-06-18 | M | D | 5,500 | $0.00 | 5,500 | D | — · — to — | 5,500 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary |